Related Experiment Video
Updated: Jul 19, 2026
17:16
Registered Bioimaging of Nanomaterials for Diagnostic and Therapeutic Monitoring
Published on: December 9, 2010
Nanomedicine: developing smarter therapeutic and diagnostic modalities
Omid C Farokhzad1, Robert Langer
1Department of Anesthesiology, Peri-operative and Pain Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA. ofarokhzad@partners.org
Advanced Drug Delivery Reviews
|October 31, 2006
Summary
Nanomedicine, the application of nanotechnology in medicine, is rapidly advancing. This review explores its past, present, and future potential in diagnostics and therapeutics.
Area of Science:
- Medical nanotechnology
- Biomedical engineering
- Materials science in medicine
Background:
- Nanotechnology's integration into medicine is accelerating.
- Novel nanoscale therapeutic and diagnostic tools are emerging.
- The field of nanomedicine is experiencing significant growth.
Purpose of the Study:
- To provide a comprehensive review of nanomedicine.
- To analyze the historical evolution of nanomedicine.
- To discuss the current state and future trajectory of nanomedicine.
Main Methods:
- Literature review of nanomedicine advancements.
- Analysis of current clinical applications of nanomedicine.
- Prospective outlook on future nanomedicine developments.
Main Results:
- Early impacts of nanotechnology in medicine are evident.
- Diverse nanoscale modalities are in development or clinical use.
- Significant progress has been made in nanodiagnostics and nanotherapeutics.
Conclusions:
- Nanomedicine represents a transformative frontier in healthcare.
- Continued innovation in nanotechnology will drive medical breakthroughs.
- The future of medicine will be increasingly influenced by nanoscale solutions.
Related Concept Videos
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:24Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...